Pregnancy outcomes in inflammatory skin diseases

被引:1
|
作者
Onan, Duru Tabanlioglu [1 ]
Yorulmaz, Ahu [1 ]
Dikmen, Asiye Ugras [2 ]
Yakut, Kadriye [3 ]
Guler, Ismail [4 ]
Atalay, Cemal Resat [3 ]
Artuz, Refika Ferda [1 ]
Yalcin, Basak [1 ]
机构
[1] Univ Hlth Sci, Ankara Numune Training & Res Hosp, Clin Dermatol, Ankara, Turkey
[2] Gazi Univ, Dept Publ Hlth, Fac Med, Ankara, Turkey
[3] Univ Hlth Sci, Ankara Numune Training & Res Hosp, Clin Obstet & Gynecol, Ankara, Turkey
[4] Gazi Univ, Dept Obstet & Gynecol, Fac Med, Ankara, Turkey
关键词
Inflammation; skin diseases; pregnancy outcome; chronic disease;
D O I
10.4274/turkderm.59260
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Design: Inflammation can lead to adverse outcomes in pregnancy. Some inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and psoriasis, are associated with preterm birth and low birth weight. The objectives of our study were to assess the effect of various inflammatory skin diseases (ISDs) on pregnancy outcomes and to evaluate the course of ISDs during pregnancy. Materials and Methods: In this multicenter cohort study, a total of 242 pregnant women in three groups including 32 pregnants with a history of ISDs, 70 pregnants with a diagnosis of systemic disease and 140 healthy pregnants were prospectively analyzed. Results: The rate of adverse pregnancy outcome was 34.4% in ISDs, 37.1% in systemic diseases and 25% in healthy pregnant groups (p=0.16). Gestational diabetes mellitus (12.5%) and thyroid dysfunction in pregnancy (9.4%) were the most common adverse outcomes of pregnancy seen in ISDs group. The disease course of ISDs was stable in 50%, improved in 28.1% and exacerbated in 21.9% of patients during pregnancy. Conclusion: We could not demonstrate a significant association between ISDs and adverse pregnancy outcomes. Most of the ISDs were either stable or improved during pregnancy.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 50 条
  • [21] Dermoscopy of inflammatory skin diseases
    Szebenyi, Julia
    Legradi, Maria
    Nemeth, Csongor
    Joura, Marie Isolde
    Gyulai, Rolland
    Lengyel, Zsuzsanna
    DERMATOLOGIE, 2023, 74 (04): : 232 - 242
  • [22] Chemokines and inflammatory skin diseases
    Homey, Bernhard
    INFLAMMATION RESEARCH, 2007, 56 : S363 - S363
  • [23] Phytotherapy for Inflammatory Skin Diseases
    Hoffmann, J.
    Woelfle, U.
    Schempp, C.
    AKTUELLE DERMATOLOGIE, 2019, 45 (07) : 325 - 331
  • [24] Chemokines and inflammatory skin diseases
    Homey, B
    Bünemann, E
    CHEMOKINE ROLES IN IMMUNOREGULATION AND DISEASE, 2003, 45 : 69 - 83
  • [25] Inflammatory skin diseases and wounds
    Dissemond, Joachim
    Romanelli, Marco
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (02) : 167 - 177
  • [26] Eicosanoids in inflammatory skin diseases
    Fogh, K
    Kragballe, K
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 63 (1-2): : 43 - 54
  • [27] Macrophages in inflammatory skin diseases and skin tumors
    Liu, Si-Han
    Zhang, Jie
    Zuo, Ya-Gang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Skin microbiome, inflammatory and allergic skin diseases
    Stamatas, Georgios
    TOXICOLOGY LETTERS, 2016, 258 : S18 - S18
  • [29] Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases
    Ahn, Soo Min
    Joo, Young Bin
    Kim, Yun Jin
    Bang, So -Young
    Lee, Hye-Soon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (22)
  • [30] Skin diseases in pregnancy: a challenge for dermatologists
    Cozzani, Emanuele
    De Simone, Clara
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2019, 154 (03): : 254 - 255